An AI model using CCTA distinguishes noncalcified plaque volumes in chest pain patients compared to asymptomatic patients.
Key Details
- 1AI model based on CCTA quantified plaque volumes in chest pain and asymptomatic patients.
- 2Study included 1,835 participants undergoing CCTA and quantitative plaque analysis from 2020-2024.
- 3Chest pain patients with midlevel CAC (100-300) had higher noncalcified plaque volume (152.3 vs. 108.9, p = 0.035).
- 4Symptomatic patients were generally younger and had lower systolic blood pressure than asymptomatic peers.
- 5No significant difference was found in statin use, hypertension, or diabetes prevalence between groups.
- 6Automated plaque analysis was performed using Cleerly software.
Why It Matters
The findings support using AI-driven CCTA analysis to help risk-stratify chest pain patients, potentially guiding preventive management decisions. Accurate plaque quantification may enhance diagnostic precision and patient care.
Source
AuntMinnie
Related News
•Radiology Business
Study Highlights Limitations of AI in Prostate MRI Screening
New research points to several shortcomings in implementing AI for MRI-based prostate cancer screening.
•AuntMinnie
Deep Learning Model Predicts Brain Tumor MRI Enhancement Without Gadolinium
German researchers developed a deep learning approach to predict MRI contrast enhancement in brain tumors without the need for gadolinium-based agents.
•Radiology Business
SimonMed Imaging Introduces Paid AI Add-Ons for Routine Exams
SimonMed Imaging is launching new AI-powered elective services for routine imaging exams with additional out-of-pocket costs for patients.